+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Oral Mucositis - Global Clinical Trials Review, 2023 - Product Thumbnail Image

Oral Mucositis - Global Clinical Trials Review, 2023

  • Clinical Trials
  • December 2023
  • 299 Pages
  • Global
From
From
From
Monoclonal Antibodies Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Monoclonal Antibodies Market - Forecasts from 2022 to 2027

  • Report
  • December 2022
  • 142 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Biobanking: Technologies and Global Markets - Product Thumbnail Image

Biobanking: Technologies and Global Markets

  • Report
  • January 2022
  • 138 Pages
  • Global
From
From
From
Ovarian Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Ovarian Cancer Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 118 Pages
  • Global
From
Bioinformatics Collaboration and Licensing Deals 2019-2025 - Product Thumbnail Image

Bioinformatics Collaboration and Licensing Deals 2019-2025

  • Report
  • May 2025
  • 450 Pages
  • Global
From
Loading Indicator